Job Title: Non-Executive Chairman
A life sciences company operating in one of the most progressive areas of biotechnological research – the modulation of the human microbiome. The Company has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases. Founded in 2012, the Company successfully listed on AIM in 2014 and has performed strongly with a current market cap of £60 million. Growth has been achieved both organically and through acquisition.
Track record of success as a Chairman/NED within the large corporate, food, nutrition and/or retail sectors
Demonstrates a track record of growing a consumer business from £10s to £100s of millions
Strong financial markets knowledge, with experience of listing on AIM and, ideally, NASDAQ
Governance: ensure the Board discharges its responsibilities effectively and in line with good practice
Investor relations/corporate finance: extensive network of investor and city contacts – inspiring investor confidence
The Company has ambitious growth plans with the aspiration to become a £600 million business. As such, the Board was seeking to appoint a new Non-Executive Chairman (NEC) to support this ambition. This key role would be a fundamental part of the organisation’s growth strategy.
PiR is a specialist recruitment company, established for over a decade, focused exclusively on identifying senior talent who deliver strategically and operationally to international life sciences organisations.
The relevance and depth of PiR’s expertise is reflected in the team’s combined life science recruitment experience of over 40 years; across key business functions at leadership and expert level. Our exclusive focus on, and network in, the sector ensures our solutions are aligned and relevant to client companies, reflecting our inherent understanding of the life science industry.
PiR’s client services include:
• Executive Search
• Interim Management Services
• Talent Mapping
PiR’s team is aligned to provide a depth of expertise across key business segments:
• Early stage, investor backed and SME organisations, as well as mid-capped specialist companies. These include advanced and novel therapies (cell, gene, and RNAbased), orphan drugs and innovative medical technology
• Building senior teams for newly funded and growing organisations
• Director, leadership and expert level; Medical/Medical Affairs, Clinical, Regulatory, Manufacturing Operations (including Quality and Supply Chain) and Commercial (HEOR, Pricing & Reimbursement, Market Access, product management)
• Board level appointments (CEO, CBO, COO, CSO, CMO, Chair, NED)
To learn more about PiR, please contact Sally Hope, CEO at firstname.lastname@example.org. Tel: + 44 (0) 1480 499580